etoposide has been researched along with Hepatoblastoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Gu, H; Hu, H; Huang, D; Li, F; Li, J; Liao, R; Wu, R; Zhang, W; Zhang, Y; Zhi, T | 1 |
| Häberle, B; Maxwell, R; Schmid, I; Schweinitz, DV | 1 |
| Auerbach, C; Cheron, R; Natarajan, E; Pashankar, F | 1 |
| Hishiki, T; Hiyama, E; Hoshino, K; Ida, K; Iehara, T; Koh, K; Kurihara, S; Onitake, Y; Oue, T; Tanaka, Y; Ueda, Y; Watanabe, K; Yano, M | 1 |
| Bode, HH; Bode, U; Schimana, W; Swai, B | 1 |
| Gutweiler, JR; Kim, HB; Kozakewich, HP; Marcus, KJ; Shamberger, RC; Weldon, CB; Yu, DC | 1 |
| Chen, J; Dong, L; Gu, LJ; Jiang, H; Pan, C; Tang, JY; Xue, HL; Ye, QD; Zhou, M | 1 |
| Hishiki, T; Hiyama, E; Horie, H; Ida, K; Kamimatsuse, A; Kondo, S; Matsunaga, T; Ohnuma, N; Oue, T; Sasaki, F; Tajiri, T; Watanabe, K; Yano, M | 1 |
| Jaiswal, AK; Niture, SK | 1 |
| Bowman, LC; Douglass, EC; Finegold, MJ; Katzenstein, HM; London, WB; Plaschkes, J; Reynolds, M | 1 |
| Gohda, E; Hamasaki, K; Namba, M; Orita, K; Seshimo, K | 1 |
| Ballard, EA; Balzer, GK; Berkow, RL; Hilliard, LM; Moertel, CL; Watterson, J | 1 |
| Fuchs, J; Haindl, J; Leuschner, I; von Schweinitz, D; Wenderoth, M | 1 |
1 trial(s) available for etoposide and Hepatoblastoma
| Article | Year |
|---|---|
Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Hepatoblastoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Metastasis; Survival Rate; Vincristine | 2002 |
12 other study(ies) available for etoposide and Hepatoblastoma
| Article | Year |
|---|---|
Individualized chemotherapy and efficacy analysis of hepatoblastoma in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Cyclophosphamide; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Vincristine | 2024 |
High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Liver Neoplasms; Neoplasm Recurrence, Local; Transplantation, Autologous; Treatment Outcome | 2019 |
Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Irinotecan; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Remission Induction | 2020 |
Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Male; Neoadjuvant Therapy; Prognosis; Treatment Outcome | 2016 |
Sexual precocity associated with an abdominal tumor in an African boy.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Etoposide; Hepatectomy; Hepatoblastoma; Humans; Liver Neoplasms; Male; Puberty, Precocious; Treatment Outcome | 2008 |
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fluorouracil; Focal Nodular Hyperplasia; Granulocyte Colony-Stimulating Factor; Hepatectomy; Hepatoblastoma; Humans; Ifosfamide; Immunoglobulin G; Incidental Findings; Liver Neoplasms; Male; Melphalan; Mesna; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neuroblastoma; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Vincristine | 2008 |
[Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Female; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Male | 2009 |
Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatoblastoma; Humans; Ifosfamide; Infant; Infant, Newborn; Japan; Liver; Liver Neoplasms; Male; Survival Analysis; Treatment Outcome | 2011 |
Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antioxidant Response Elements; Antioxidants; Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Cell Survival; Cytoprotection; Drug Resistance, Neoplasm; Etoposide; HEK293 Cells; Hepatoblastoma; Humans; Hydroquinones; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Mice; NF-E2-Related Factor 2; Promoter Regions, Genetic; RNA Interference | 2013 |
[Effects of cisplatin, carboplatin, etoposide and human hepatocyte growth factor on the colony formation of four human liver cancer cell lines].
Topics: Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Drug Synergism; Etoposide; Hepatoblastoma; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Neoplastic Stem Cells; Recombinant Proteins; Tumor Cells, Cultured | 1993 |
Retinal toxicity associated with cisplatin and etoposide in pediatric patients.
Topics: Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Cisplatin; Depth Perception; Etoposide; Evoked Potentials, Visual; Fatal Outcome; Female; Germinoma; Hepatoblastoma; Humans; Liver Neoplasms; Retina; Retroperitoneal Neoplasms; Visual Acuity | 1997 |
Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Carboplatin; Cell Division; Child, Preschool; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Hepatoblastoma; Humans; Ifosfamide; Infant; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1998 |